Impact of Tamoxifen on Amount of Fibroglandular Tissue, Background Parenchymal Enhancement, and Cysts on Breast Magnetic Resonance Imaging

Oksa, 2009, Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia, Acta Radiol, 50, 984, 10.3109/02841850903168083

Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371

Rutqvist, 1991, Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy, J Natl Cancer Inst, 83, 1299, 10.1093/jnci/83.18.1299

Nayfield, 1991, Potential role of tamoxifen in prevention of breast cancer, J Natl Cancer Inst, 83, 1450, 10.1093/jnci/83.20.1450

Early Breast Cancer Trialists’ Collaborative Group, 1998, Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet, 351, 1451, 10.1016/S0140-6736(97)11423-4

Early Breast Cancer Trialists’ Collaborative Group, 1992, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women, Lancet, 339, 1, 10.1016/0140-6736(92)90997-H

Kuhl, 1997, Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency, Radiology, 203, 137, 10.1148/radiology.203.1.9122382

Muller-Schimpfle, 1997, Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast, Radiology, 203, 145, 10.1148/radiology.203.1.9122383

Hussain, 1999, Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology, Br J Radiol, 72, 236, 10.1259/bjr.72.855.10396212

Graham, 1995, Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 T, J Magn Reson Imaging, 5, 695, 10.1002/jmri.1880050613

Delille, 2005, Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging-initial observations, Radiology, 235, 36, 10.1148/radiol.2351040012

Harvey, 2008, Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices, Menopause, 15, 67, 10.1097/gme.0b013e318054e29a

Pfleiderer, 2004, Changes in magnetic resonance mammography due to hormone replacement therapy, Breast Cancer Res, 6, R232, 10.1186/bcr779

Morris, 2007, Diagnostic breast MR imaging: current status and future directions, Radiol Clin North Am, 45, 863, 10.1016/j.rcl.2007.07.002

Kuhl, 2007, The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice, Radiology, 244, 356, 10.1148/radiol.2442051620

Son, 1999, Significance of follow-up mammography in estimating the effect of tamoxifen in breast cancer patients who have undergone surgery, AJR Am J Roentgenol, 173, 905, 10.2214/ajr.173.4.10511146

Mousa, 2008, Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy, Menopause, 15, 875, 10.1097/gme.0b013e31816956c3

American College of Radiology, 2003, Breast Imaging Reporting and Data System (BI-RADS)

Eng-Wong, 2008, Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer, Cancer Epidemiol Biomarkers Prev, 17, 1696, 10.1158/1055-9965.EPI-07-2752

Cuzick, 2011, Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study, J Natl Cancer Inst, 103, 744, 10.1093/jnci/djr079

King, 2011, Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk, Radiology, 260, 50, 10.1148/radiol.11102156

American College of Radiology BI-RADS Committee, 2003, Breast Imaging Reporting and Data System

Finlayson, 2003, MRI is a potential intermediate marker for tamoxifen response in breast cancer prevention, Breast Cancer Res Tr, 82, S178